Top 10 Seed Investors: Biotechnology, Pharma & Life Sciences
| Rank | Investor Name |
|---|---|
| 1 | SOSV |
| 2 | IndieBio |
| 3 | Draper Associates |
| 4 | Y Combinator |
| 5 | Alumni Ventures |
| 6 | Pioneer Fund |
| 7 | ZAKA VC |
| 8 | Plug and Play Tech Center |
| 9 | Khosla Ventures |
| 10 | Luxe Capital Partners LLC |
Seed activity in this category runs heavily through the accelerator ecosystem and the funds that follow its cohorts. Platform science and pharma partnership appetite drive the category, with specialist funds leading most rounds. For a company raising at this stage, these are the highest-velocity check writers in the category, and the accelerator and syndicate paths are often the most direct way to reach them.
The CapitalDart directory identifies the right person to contact at each of these firms, with their individual investment criteria.
Rankings reflect investment activity from January 2025 through July 2026 in US and Canada companies, based on transactions matched to the CapitalDart directory. Seed and Early Stage rank by participation, Later Stage by rounds led, Private Equity by control and buyout activity. Updated periodically.